A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors
Clinical trial NCT05528055 · RECRUITING
Trial details
- NCT number
- NCT05528055
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2027-10-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.